Zhang Yu-Yan, Wan Hai-Tong, Lai Li-Li, Yang Jie-Hong, Chen Wei-Yan, Zhou Hui-Fen, Zhu Zhen-Hong
Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yao Xue Xue Bao. 2012 Sep;47(9):1153-8.
To observe the effect and mechanism of Yiqi Tongluo Jiedu capsule aganist cerebral ischemia reperfusion injury, the SD rats were randomly divided into following groups: sham-operated group, model group, the group of low, medium and high dose of Yiqi Tongluo Jiedu capsule, and nimodipine group. Using focal middle cerebral artery embolization (MCAO) model, following items were observed: symptoms of neurological deficit score; infarct volume; activity of SOD, content of MDA and NO, activity of NOS of ischemic brain tissue; Bcl-2 and Bax protein expression; content of IL-1beta, IL-6 and TNFalpha in serum; IL-1beta mRNA expression of ischemic brain tissue. Results showed that Yiqi Tongluo Jiedu capsule could significantly reduce the symptoms of neurological deficits, promote the recovery symptoms of neurological deficits; narrow infarct volume of brain tissue obviously, reduce the percentage of infarct volume; raise activity of SOD, reduce content of MDA and NO, reduce activity of NOS; increase Bcl-2 protein, reduce Bax expression; reduce content of IL-1beta, IL-6 and TNFa in serum; reduce IL-1beta mRNA expression of ischemic brain tissue. Yiqi Tongluo Jiedu capsule has significant protective effects against ischemic brain injury, it has significant anti-apoptotic, antioxidant and anti-inflammatory effects.
为观察益气通络解毒胶囊对脑缺血再灌注损伤的作用及机制,将SD大鼠随机分为以下几组:假手术组、模型组、益气通络解毒胶囊低、中、高剂量组及尼莫地平组。采用局灶性大脑中动脉栓塞(MCAO)模型,观察以下指标:神经功能缺损评分症状;梗死体积;缺血脑组织超氧化物歧化酶(SOD)活性、丙二醛(MDA)和一氧化氮(NO)含量、一氧化氮合酶(NOS)活性;Bcl-2和Bax蛋白表达;血清白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和肿瘤坏死因子α(TNFα)含量;缺血脑组织IL-1β mRNA表达。结果显示,益气通络解毒胶囊可显著减轻神经功能缺损症状,促进神经功能缺损症状恢复;明显缩小脑组织梗死体积,降低梗死体积百分比;提高SOD活性,降低MDA和NO含量,降低NOS活性;增加Bcl-2蛋白表达,降低Bax表达;降低血清IL-1β、IL-6和TNFα含量;降低缺血脑组织IL-1β mRNA表达。益气通络解毒胶囊对缺血性脑损伤具有显著保护作用,具有显著的抗凋亡、抗氧化和抗炎作用。